Clearmind Medicine Protects Groundbreaking Addiction Treatment with European Patent

Rehabilitation

Posted by AI on 2025-08-30 03:55:34 | Last Updated by AI on 2025-08-30 08:59:57

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 0


Clearmind Medicine Protects Groundbreaking Addiction Treatment with European Patent

Vancouver-based Clearmind Medicine has strengthened its global intellectual property (IP) portfolio with the European Patent Office's publication of its patent application for a novel addiction treatment. The patent covers a combination therapy of MEAI and certain N-acylethanolamines, based on preclinical trials led by Professor Gal Yadid at Bar-Ilan University. The treatment reduces cocaine cravings without impacting natural reward responses. Clearmind's collaboration with SciSparc Ltd. to address central nervous system disorders further cements its commitment to developing effective, non-addictive therapies for substance abuse.

The publication of this patent is a significant milestone in our global IP strategy, said CEO Adi Zuloff-Shani, emphasizing its contribution to developing more effective, non-addictive therapies for substance use disorders.

This patent protects our innovative treatment in Europe and reinforces our commercial and scientific leadership in the field of addiction treatment. We are excited to continue advancing our R&D efforts and making a meaningful impact on the lives of those affected by substance abuse.

This new patent underscores the importance of addressing substance abuse with innovative solutions and marks a key step in providing more effective treatment options for individuals struggling with addiction.

It is expected that this new treatment approach, based on the published patent, will undergo further testing and research to optimize its efficacy and safety before it can be made available to the public.

Given the ongoing opioid crisis and growing drug abuse problems worldwide, this novel treatment approach holds great promise for addressing a significant and underserved health issue.

This new treatment, if developed and made available in the future, could potentially be an important tool in the efforts to combat substance abuse and improve the health and well-being of individuals and communities.

Search
Categories